July 2026
Preliminary Pricing Supplement No. 17,304
Registration Statement Nos. 333-293641; 333-293641-01
Dated July 10, 2026
Filed pursuant to Rule 424(b)(2)
Morgan Stanley Finance LLC
Floating Rate Callable Notes due July 24, 2031
10-Year Constant Maturity Treasury... (continue reading...)
http://archive.fast-edgar.com/20260713/A8ZZ822CZW2282UH222Q2WZ288E9Z72SZY82
Filed on: July 13, 2026
http://archive.fast-edgar.com/20260713/AJZZBQ2CJC22DZZZ2Z2M2ZZB9JMHZ22IZQ82
Filed on: July 13, 2026
As filed with the Securities and Exchange Commission on July 13, 2026
Registration No. 333-289575
Registration No. 333-281486
Registration No. 333-274183
Registration No. 333-273555
Registration No. 333-265247
Registration No. 333-262881
Registration No. 333-253414
Registration No. 333-243757
Registration No. 333-236712
Registration No. 333-228994
Registration No. 333-223105
Registration No. 333-218084
Registration No. 333-216169
Registration No.... (continue reading...)
As filed with the Securities and Exchange Commission on July 13, 2026
Registration No. 333-289575
Registration No. 333-281486
Registration No. 333-274183
Registration No. 333-273555
Registration No. 333-265247
Registration No. 333-262881
Registration No. 333-253414
Registration No. 333-243757
Registration No. 333-236712
Registration No. 333-228994
Registration No. 333-223105
Registration No. 333-218084
Registration No. 333-216169
Registration No.... (continue reading...)
More SEC Filings
View Older Stories-
Form N-PX Next Capital Management For: Jun 30
-
Form ABS-15G Pepper Money Ltd For: Jul 13
-
Form 424B2 MORGAN STANLEY
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form S-8 POS Esperion Therapeutics,
-
Form 424B2 MORGAN STANLEY
-
Form D Arrowhead Laydown, LLC
-
Form 8-K CHESAPEAKE UTILITIES For: Jul 13
-
Form D/A ALM First Capital Fund
-
Form 424B4 Elong Power Holding Ltd.
-
Form 424B2 MORGAN STANLEY
-
Form S-8 POS Esperion Therapeutics,
-
Form S-8 POS Esperion Therapeutics,
-
Form 13F-HR GODSEY & GIBB, INC For: Jun 30
-
Form 424B2 MORGAN STANLEY
-
Form S-8 POS Esperion Therapeutics,
-
Form S-8 POS Esperion Therapeutics,
-
Form S-8 POS Esperion Therapeutics,
-
Form 497 Rayliant Funds Trust
-
Form S-8 POS Esperion Therapeutics,
-
Form S-8 POS Esperion Therapeutics,
-
Form FWP BofA Finance LLC Filed by: BofA Finance LLC
-
Form S-8 POS Esperion Therapeutics,
-
Form FWP BANK OF AMERICA CORP Filed by: BANK OF AMERICA CORP /DE/
-
Form 424B2 BofA Finance LLC
-
Form S-8 POS Esperion Therapeutics,
-
Form 13F-HR Perennial Advisors, LLC For: Jun 30
-
Form 6-K Lloyds Banking Group For: Jul 13
-
Form D Crayhill StepStone ABF
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form 4 Oncology Institute, Inc. For: Jul 10 Filed by: Chernett Jorey
-
Form 13F-HR ARDSLEY ADVISORY PARTNER For: Jun 30
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 MORGAN STANLEY
-
Form 424B2 MORGAN STANLEY
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 Fundrise Real Estate For: Jul 10 Filed by: Starr Gayle P
-
Form 4 NorthWestern Energy Grou For: Jul 09 Filed by: Ide Britt E
-
Form 424B2 MORGAN STANLEY
-
Form 424B2 MORGAN STANLEY
-
Form 6-K COCA-COLA EUROPACIFIC For: Jul 13
-
Form D Alluvial Qualified Partn
-
Form 13F-HR Generali Investments For: Jun 30
-
Form 424B2 MORGAN STANLEY
-
Form 4 NorthWestern Energy Grou For: Jul 09 Filed by: Goodin David L
-
Form 424B2 MORGAN STANLEY
-
Form 6-K GSK plc For: Jul 13
-
Form 4 NorthWestern Energy Grou For: Jul 09 Filed by: Edwards Sherina M.
-
Form D Creative Planning Employ
-
Form 13F-HR WOODSTOCK CORP For: Jun 30

